Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer

Cancer Research

Volumn 58, Issue 22, 1998, Pages 5038-5041

  Bailey, L Renee ^a   Roodi, Nady ^a   Dupont, William D ^a   Parl, Fritz F ^a,b  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1B1; CYTOCHROME P450 ISOENZYME; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN METABOLISM; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT;

AFRICAN CONTINENTAL ANCESTRY GROUP; ARYL HYDROCARBON HYDROXYLASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; ESTRADIOL; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FEMALE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 0032533859     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Hayes, C. L., Spink, D. C., Spink, B. C., Cao, J. Q., Walker, N. J., and Sutter, T. R. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. USA, 93: 9776-9781, 1996.
2. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P., and Sutter, T. R. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res., 56: 2979-2984, 1996.
3. Spink, D. C., Eugster, H., Lincoln, D. W. I., Schuetz, J. D., Schuetz, E. G., Johnson, J. A., Kaminsky, L. S., and Gierthy, J. F. 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1A1: a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Arch. Biochem. Biophys., 293: 342-348, 1992.
4. Li, J. J., and Li, S. A. Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed. Proc., 46: 1858-1863, 1987.
5. Liehr, J. G., and Ricci, M. J. 4-Hydroxylation of estrogens as marker of human mammary tumors. Proc. Natl. Acad. Sci. USA, 93: 3294-3296, 1996.
6. Huang, Z., Fasco, M. J., Figge, H. L., Keyomarsi, K., and Kaminsky, L. S. Expression of cytochromes P450 in human breast tissue and tumors. Drug Metab. Dispos., 24: 899-905, 1996.
7. Spink, D. C., Spink, B. C., Cao, J. Q., DePasquale, J. A., Pentecost, B. T., Fasco, M. J., Li, Y., and Sutter, T. R. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis (Lond.), 19: 291-298, 1998.
8. Breslow, N. E., and Day, N. E. The analysis of case-control studies. In: Statistical Methods in Cancer Research. Lyon, France: IRAC Scientific Publications, 1980.
9. Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. P., Jabs, E. W., Li, X., Yin, H., Cody, C. W., and Greenlee, W. F. Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J. Biol. Chem., 269: 13092-13099, 1994.
10. Bejjani, B. A., Lewis, R. A., Tomey, K. F., Andersen, K. L., Dueker, D. K., Jabak, M., Astle, W. F., Otterud, B., Leppert, M., and Lupski, J. R. Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudia Arabia. Am. J. Hum. Genet., 62: 325-333, 1998.
11. Stoilov, I., Akarsu, A. N., and Sarfarazi, M. Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (Buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum. Mol. Genet., 6: 641-647, 1997.
12. Crofts, F., Cosma, G. N., Currie, D., Taioli, E., Toniolo, P., and Garte, S. J. A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis (Lond.), 14: 1729-1731, 1993.
13. Bailey, L. R., Roodi, N., Verrier, C. S., Yee, C. J., Dupont, W. D., and Parl, F. F. Breast cancer and CYP1A1, GSTM1, and GSTT1 polymorphisms: evidence of a lack of association in Caucasians and African Americans. Cancer Res., 58: 65-70, 1998.
14. Waxman, D. J., Lapenson, D. P., Aoyama, T., Gelboin, H. V., Gonzalez, F. J., and Korzekwa, K. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch. Biochem. Biophys., 290: 160-166, 1991.
15. Yager, J. D., and Liehr, J. G. Molecular mechanisms of estrogen carcinogenesis. Annu. Rev. Pharmacol. Toxicol., 36: 203-232, 1996.
16. Ambrosone, C. B., Freudenheim, J. L., Graham, S., Marshall, J. R., Vena, J. E., Brasure, J. R., Laughlin, R., Nemoto, T., Michalek, A. M., Harrington, A., Ford, T. D., and Shields, P. G. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res., 55: 3483-3485, 1995.
17. Rebbeck, T., Resvold, E. A., Duggan, D. J., Zhang, J., and Buetow, K. H. Genetics of CYP1A1: coamplification of specific alleles by polymerase chain reaction and association with breast cancer. Cancer Epidemiol. Biomark. Prev., 3: 511-514, 1994.
18. Taioli, E., Trachman, J., Chen, X., Toniolo, P., and Garte, S. J. A CYP1A1 restriction fragment length polymorphism is associated with breast cancer in African-American women. Cancer Res., 55: 3757-3758, 1995.
19. Cicatiello, L., Cobellis, G., Addeo, R., Papa, M., Altucci, L., Sica, V., Bresciani, F., LeMeur, M., Kumar, V. L., Chambon, P., and Weisz, A. In vivo functional analysis of the mouse estrogen receptor gene promoter: a transgenic mouse model to study tissue-specific and developmental regulation of estrogen receptor gene transcription. Mol. Endocrinol., 9: 1077-1090, 1995.
20. Kaneko, K. J., Furlow, J. D., and Gorski, J. Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation. Mol. Endocrinol., 7: 879-888, 1993.
21. Read, L. D., Greene, G. L., and Katzenellenbogen, B. S. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Mol. Endocrinol., 3: 295-304, 1989.
22. Martin, M. B., Saceda, M., Garcia-Morales, P., and Gottardis, M. M. Regulation of estrogen receptor expression. Breast Cancer Res. Treat., 31: 183-189, 1994.
23. Eley, J. W., Hill, H. A., Chen, V. W., Austin, D. F., Wesley, M. N., Muss, H. B., Greenberg, R. S., Coates, R. J., Correa, P., and Redmond, C. K. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. J. Am. Med. Assoc., 272: 947-954, 1994.
24. Elledge, R. M., Clark, G. M., Chamness, G. C., and Osborne, C. K. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J. Natl. Cancer Inst., 86: 705-712, 1994.
25. Zhang, Z., Fasco, M. J., Huang, L., Guengerich, F. P., and Kaminsky, L. S. Characterization of purified human recombinant cytochrome P4501A1-Ile 462 and -Val 462: assessment of a role for the rare allele in carcinogenesis. Cancer Res., 56: 3926-3933, 1996.